Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Industry Decries Broad MDD Regrouping Sought By UK, France

This article was originally published in The Gray Sheet

Executive Summary

Upclassification of artificial joint products under the Medical Devices Directive (MDD) could result in an EU market shortage of devices used in hip replacement surgery, according to European manufacturers

You may also be interested in...



Stryker UK ABG I Acetabular Cup Wear Cited In MHRA Medical Device Alert

Clinical centers reporting problems with Stryker UK's ABG I uncemented acetabular cups had lower implant survival rates than centers not reporting problems, according to a clinical audit by UK's Medicines & Healthcare Products Regulatory Agency (MHRA)

International News In Brief

Quality systems technical report: Final version of Technical Report 14969, which provides guidance on device use quality systems standard ISO 13485:2003, is expected by late spring or early summer, BSI Assistant VP-Product Services Paul Brooks tells participants at Regulatory Affairs Professionals Society Principles & Practices of EU Regulatory Affairs meeting Feb. 23-24 in Arlington,Va. TR 14969 previously was a guidance standard, but was changed to a technical report with the update of ISO 13485 (1"The Gray Sheet" July 2, 2001, p. 14). The ISO quality standard will replace its 1996 predecessor in July 2006...

Stryker UK ABG I Acetabular Cup Wear Cited In MHRA Medical Device Alert

Clinical centers reporting problems with Stryker UK's ABG I uncemented acetabular cups had lower implant survival rates than centers not reporting problems, according to a clinical audit by UK's Medicines & Healthcare Products Regulatory Agency (MHRA)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017963

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel